Vitreomacular Adhesion Clinical Trial
Official title:
A Randomized, Placebo Controlled, Double-masked, Multicenter Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion.
This trial will evaluate the safety and efficacy of microplasmin, administered as an intravitreal injection, in subjects with focal vitreomacular adhesion. In previously performed clinical trials, some patients treated with intravitreal microplasmin have had resolution of their underlying condition, including macular hole closure, without need for vitrectomy. This clinical trial is justified because the sponsor believes the potential benefits outweigh the potential risks.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01966328 -
A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment
|
Phase 1 | |
| Withdrawn |
NCT02001701 -
Intravitreal Gas for Vitreomacular Adhesion
|
N/A | |
| Completed |
NCT02322229 -
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion
|
Phase 4 | |
| Completed |
NCT02160340 -
Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older
|
||
| Completed |
NCT00781859 -
Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.
|
Phase 3 | |
| Completed |
NCT02035748 -
Assessment of Patients Treated With JETREA® for Vitreomacular Traction
|
Phase 4 |